| CTRI Number |
CTRI/2023/01/048887 [Registered on: 11/01/2023] Trial Registered Prospectively |
| Last Modified On: |
13/06/2023 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Surgical/Anesthesia |
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
Effect of painkillers and its comparison with local injection in laparoscopic (key hole surgery ) for gall bladder stone surgery |
|
Scientific Title of Study
|
Efficacy of the laparoscopic subcostal transversus abdominis plane block vs conventional analgesia in laparoscopic cholecystectomy: a randomized controlled trial |
| Trial Acronym |
STAP |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Agrawal Kavita Khemchand |
| Designation |
Assistant Professor |
| Affiliation |
Dr. B. R. Ambedkar Institute of Medical Sciences, MOHALI |
| Address |
Department of General Surgery, Room 103, First floor ,Block 1 District hospital, Mohali
Rupnagar PUNJAB 160055 India |
| Phone |
7087438617 |
| Fax |
|
| Email |
drkavitaagrawal@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Agrawal Kavita Khemchand |
| Designation |
Assistant Professor |
| Affiliation |
Dr. B. R. Ambedkar Institute of Medical Sciences, MOHALI |
| Address |
Department of General Surgery, Room 103, First floor ,Block 1 District hospital, Mohali
Rupnagar PUNJAB 160055 India |
| Phone |
7087438617 |
| Fax |
|
| Email |
drkavitaagrawal@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Agrawal Kavita Khemchand |
| Designation |
Assistant Professor |
| Affiliation |
Dr. B. R. Ambedkar Institute of Medical Sciences, MOHALI |
| Address |
Department of General Surgery, Room 103, First floor ,Block 1 District hospital, Mohali
Rupnagar PUNJAB 160055 India |
| Phone |
7087438617 |
| Fax |
|
| Email |
drkavitaagrawal@gmail.com |
|
|
Source of Monetary or Material Support
|
| Dr. B. R. Ambedkar State Institue of Medical Sciences, mohali |
|
|
Primary Sponsor
|
| Name |
Dr. B. R. Ambedkar State Institue of Medical Sciences, mohali |
| Address |
phase 6, Mohali, 160055 |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Agrawal Kavita Khemchand |
Dr. B. R. Ambedkar state Institute of medical sciences |
first floor, district hospital, Mohali Rupnagar PUNJAB |
7087438617
drkavitaagrawal@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: O||Medical and Surgical, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
STAP Block ropivacaine group |
20ml of 0.25% ropivacaine instilled laparoscopic guided transverses abdominis plane before surgical closure |
| Comparator Agent |
conventional analgesia (intravenous diclofenac) |
conventional analgesia consisting of intravenous injection of diclofenac 75mg given 8th hourly in postoperative period |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
80.00 Year(s) |
| Gender |
Both |
| Details |
1. Age >18-80 years
2. Patients scheduled to undergo laparoscopic cholecystectomy
|
|
| ExclusionCriteria |
| Details |
1. Patient refusal to give consent to participate in the study
2. Patients with history of allergy to local anesthetics
3. Patients who get converted to open cholecystectomy
4. Patients with acute cholecystitis
5. Significant liver or renal disease
6. Abdominal drain use
7. Opioid addict patients
|
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant and Outcome Assessor Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Evaluation of visual analog scale score during first 24 hours post operatively. |
Evaluation of visual analog scale score at extubation, 1,2,3,6,12, and 24 hours post operatively |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| requirement of rescue analgesia |
0, 4, 8, 12, 16, 20, 24 hours postoperatively |
|
|
Target Sample Size
|
Total Sample Size="90" Sample Size from India="90"
Final Enrollment numbers achieved (Total)= "90"
Final Enrollment numbers achieved (India)="90" |
|
Phase of Trial
|
Post Marketing Surveillance |
|
Date of First Enrollment (India)
|
15/01/2023 |
| Date of Study Completion (India) |
12/06/2023 |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Date Missing |
|
Estimated Duration of Trial
|
Years="0" Months="3" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Completed |
| Recruitment Status of Trial (India) |
Completed |
|
Publication Details
|
|
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - All of the individual participant data collected during the trial, after de-identification.
- What additional supporting information will be shared?
Response - Study Protocol Response - Statistical Analysis Plan Response - Informed Consent Form Response - Clinical Study Report Response - Analytic Code
- Who will be able to view these files?
Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.
- For what types of analyses will this data be available?
Response - Any purpose.
- By what mechanism will data be made available?
Response - Proposals should be directed to [drkavitaagrawal@gmail.com].
- For how long will this data be available start date provided 01-04-2023 and end date provided 01-10-2023?
Response - Immediately following publication. No end date.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - NIL
|
|
Brief Summary
|
Many patients experience moderate to severe pain after laparoscopic cholecystectomy. Some studies have shown beneficial effects of subcostal transversus abdominis plane block on reducing this pain and opioid requirement following the surgery. Thus, it may also improve the efficiency by reducing time to discharge. Laparoscopic-guided subcostal TAP block is an alternate technique where ultrasound or its technical expertise are not available. Our goal is to investigate efficacy of laparoscopic subcostal TAP block vs conventional analgesia in patients undergoing laparoscopic cholecystectomy. |